Medications Used Among Nonhospitalized Pregnant Women With <scp>COVID</scp> ‐19: A Prospective Individual Patient Data Meta‐Analysis in Europe and North America

This international meta-analysis reveals low medication use and country-specific variations, enhancing insight into the management of COVID-19 in nonhospitalized pregnant women. Higher antithrombotic use post-COVID-19 suggests prophylactic treatment in this population, but variation between countries emphasizes the challenges of combining multinational data.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2025-12-25
DOI
https://doi.org/10.1002/pds.70303
Primary Topic
COVID-19 Impact on Reproduction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medications Used Among Nonhospitalized Pregnant Women With COVID ‐19: A Prospective Individual Patient Data Meta‐Analysis in Europe and North America

Émeline Maisonneuve, Eimir Hurley, P. Kaul, Olga Paoletti et al.
Pharmacoepidemiology and Drug Safety
COVID-19 Impact on Reproduction
article

Medications Used Among Nonhospitalized Pregnant Women With COVID ‐19: A Prospective Individual Patient Data Meta‐Analysis in Europe and North America

Émeline Maisonneuve, Eimir Hurley, P. Kaul, Olga Paoletti, Odette de Bruin, Elizabeth Messenger‐Jones, Odile E Sheehy, Fariba Ahmadizar, Satu J. Siiskonen, David Hägg, Corinne S de Vries, Maria E. Kempner, Ema Alsina, Kelly Plueschke, Daniel S. Thayer, Jennifer G. Lyons, Austin Cosgrove, Carolyn E. Cesta, Leyla Şahin, Alice Panchaud, Sue Jordan, Sengwee Toh, Rosa Gini, Marie‐Agnès Bernard, Miriam C J M Sturkenboom, Mayura U Shinde, Hedvig M E Nordeng, Kitty W M Bloemenkamp, Régis Lassalle, Guillaume Favre, Clara L. Rodríguez‐Bernal, Beatriz Poblador‐Plou, Wei Hua, José J. Hernández‐Muñoz, Francisco Sánchez‐Sáez, Anick Bérard
article en

Abstract

This international meta-analysis reveals low medication use and country-specific variations, enhancing insight into the management of COVID-19 in nonhospitalized pregnant women. Higher antithrombotic use post-COVID-19 suggests prophylactic treatment in this population, but variation between countries emphasizes the challenges of combining multinational data.

Pharmacoepidemiology and Drug SafetyVol. 35(1)
University of Bern (CH), European Medicines Agency (NL), Bern University of Applied Sciences (CH), Norwegian Institute of Public Health (NO), Center for Drug Evaluation and Research (US), Harvard University (US), Université de Bordeaux (FR), University of Alberta (CA), Inserm (FR), University of Oslo (NO), Science for Life Laboratory (SE), Centre Hospitalier Universitaire Sainte-Justine (CA), Karolinska Institutet (SE), University Medical Center Utrecht (NL), Swansea University (GB), Cal Humanities (US), Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES), Harvard Pilgrim Health Care (US), Pharmo Institute (NL), Mother Hospital (IN), Instituto de Investigación Sanitaria Aragón (ES), Agenzia Regionale di Sanità della Toscana (IT), Research Network (United States) (US), Wilhelmina Children's Hospital (NL), Centre d'Investigation Clinique Plurithématique de Bordeaux, Université de Montréal (CA), University of Lausanne (CH)
Universiteit Utrecht, U.S. Food and Drug Administration, Canadian Institutes of Health Research
Openalex Percentile: Top 26%
COVID-19 Impact on Reproduction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.